Literature DB >> 18612085

Astrocyte responses after neonatal ischemia: the yin and the yang.

Sonia Villapol1, Antoinette Gelot, Sylvain Renolleau, Christiane Charriaut-Marlangue.   

Abstract

Neonatal encephalopathy is a major predictor of neurodevelopmental disability in term infants and occurs in 1 to 6 of every 1,000 live term births. Despite improvements in perinatal practice during the past several decades, the incidence of cerebral palsy attributed to neonatal asphyxia remained essentially unchanged, primarily because management strategies were supportive and not targeted toward the processes of ongoing injury. Traditionally, experimental research in vivo focused on neurons, and more recently, oligodendrocytes whereas astrocytes have been more or less neglected. This review aims at dissecting possible protective as well as destructive roles of astrocytes in the immature ischemic brain to stimulate further research into this unexplored aspect of brain pathophysiology.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18612085     DOI: 10.1177/1073858408316003

Source DB:  PubMed          Journal:  Neuroscientist        ISSN: 1073-8584            Impact factor:   7.519


  10 in total

1.  Maternal inflammation leads to impaired glutamate homeostasis and up-regulation of glutamate carboxypeptidase II in activated microglia in the fetal/newborn rabbit brain.

Authors:  Zhi Zhang; Bassam Bassam; Ajit G Thomas; Monica Williams; Jinhuan Liu; Elizabeth Nance; Camilo Rojas; Barbara S Slusher; Sujatha Kannan
Journal:  Neurobiol Dis       Date:  2016-06-17       Impact factor: 5.996

Review 2.  Cannabinoids in Neurodegenerative Disorders and Stroke/Brain Trauma: From Preclinical Models to Clinical Applications.

Authors:  Javier Fernández-Ruiz; María A Moro; José Martínez-Orgado
Journal:  Neurotherapeutics       Date:  2015-10       Impact factor: 7.620

3.  Temporal dynamics of cerebral blood flow, cortical damage, apoptosis, astrocyte-vasculature interaction and astrogliosis in the pericontusional region after traumatic brain injury.

Authors:  Sonia Villapol; Kimberly R Byrnes; Aviva J Symes
Journal:  Front Neurol       Date:  2014-06-04       Impact factor: 4.003

4.  A Battery of Motor Tests in a Neonatal Mouse Model of Cerebral Palsy.

Authors:  Danielle N Feather-Schussler; Tanya S Ferguson
Journal:  J Vis Exp       Date:  2016-11-03       Impact factor: 1.355

Review 5.  A Model of Perinatal Ischemic Stroke in the Rat: 20 Years Already and What Lessons?

Authors:  Christiane Charriaut-Marlangue; Olivier Baud
Journal:  Front Neurol       Date:  2018-08-07       Impact factor: 4.003

6.  Sildenafil improves hippocampal brain injuries and restores neuronal development after neonatal hypoxia-ischemia in male rat pups.

Authors:  Armin Yazdani; Belal Howidi; Meng Zhu Shi; Nicol Tugarinov; Zehra Khoja; Pia Wintermark
Journal:  Sci Rep       Date:  2021-11-11       Impact factor: 4.379

7.  Cannabinoids: well-suited candidates for the treatment of perinatal brain injury.

Authors:  David Fernández-López; Ignacio Lizasoain; Maria Angeles Moro; José Martínez-Orgado
Journal:  Brain Sci       Date:  2013-07-10

8.  Neuroprotective effects of Ilexonin A following transient focal cerebral ischemia in rats.

Authors:  Ai-Ling Xu; Guan-Yi Zheng; Zhi-Jian Wang; Xiao-Dong Chen; Qiong Jiang
Journal:  Mol Med Rep       Date:  2016-02-22       Impact factor: 2.952

9.  Partial Reversal of Striatal Damage by Palmitoylethanolamide Administration Following Perinatal Asphyxia.

Authors:  Lucas D Udovin; Tamara Kobiec; María I Herrera; Nicolás Toro-Urrego; Carlos F Kusnier; Rodolfo A Kölliker-Frers; Ana B Ramos-Hryb; Juan P Luaces; Matilde Otero-Losada; Francisco Capani
Journal:  Front Neurosci       Date:  2020-01-08       Impact factor: 4.677

Review 10.  Midkine: The Who, What, Where, and When of a Promising Neurotrophic Therapy for Perinatal Brain Injury.

Authors:  Emily Ross-Munro; Faith Kwa; Jenny Kreiner; Madhavi Khore; Suzanne L Miller; Mary Tolcos; Bobbi Fleiss; David W Walker
Journal:  Front Neurol       Date:  2020-10-22       Impact factor: 4.003

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.